PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.99%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-3.25%
Negative gross profit growth while 3391.T is at 0.81%. Joel Greenblatt would examine cost competitiveness or demand decline.
-19.17%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-27.13%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-25.66%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-25.65%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-25.65%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Share reduction while 3391.T is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3391.T is at 0.02%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
5.51%
Similar OCF growth to 3391.T's 6.05%. Walter Schloss would assume comparable operations or industry factors.
5.51%
FCF growth similar to 3391.T's 6.05%. Walter Schloss would attribute it to parallel capital spending and operational models.
27.44%
10Y revenue/share CAGR under 50% of 3391.T's 177.94%. Michael Burry would suspect a lasting competitive disadvantage.
49.80%
5Y revenue/share CAGR at 75-90% of 3391.T's 57.20%. Bill Ackman would encourage strategies to match competitor’s pace.
23.09%
3Y revenue/share CAGR 1.25-1.5x 3391.T's 15.51%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.42%
Below 50% of 3391.T's 112.97%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
53.29%
5Y net income/share CAGR above 1.5x 3391.T's 16.61%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
29.45%
3Y net income/share CAGR above 1.5x 3391.T's 3.98%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
143.96%
10Y equity/share CAGR at 75-90% of 3391.T's 179.05%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
100.32%
5Y equity/share CAGR above 1.5x 3391.T's 52.22%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
49.44%
3Y equity/share CAGR above 1.5x 3391.T's 22.04%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
112.50%
Below 50% of 3391.T's 366.00%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
88.89%
5Y dividend/share CAGR 1.25-1.5x 3391.T's 66.43%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
70.00%
3Y dividend/share CAGR 1.25-1.5x 3391.T's 57.43%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
29.48%
AR growth well above 3391.T's 5.49%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.13%
Inventory growth well above 3391.T's 2.84%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.50%
Asset growth at 75-90% of 3391.T's 1.98%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
2.47%
75-90% of 3391.T's 3.01%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-8.57%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
3.12%
SG&A growth well above 3391.T's 4.27%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.